Nano Cap New Millennium Growth Fund L P Purchases New Position in 908 Devices Inc. $MASS

Nano Cap New Millennium Growth Fund L P acquired a new position in 908 Devices Inc. (NASDAQ:MASS) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 120,000 shares of the company’s stock, valued at approximately $630,000. Nano Cap New Millennium Growth Fund L P owned approximately 0.33% of 908 Devices at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. First Light Asset Management LLC raised its holdings in 908 Devices by 135.2% in the 3rd quarter. First Light Asset Management LLC now owns 2,510,496 shares of the company’s stock worth $21,992,000 after purchasing an additional 1,442,883 shares in the last quarter. Geode Capital Management LLC raised its holdings in 908 Devices by 11.7% in the 2nd quarter. Geode Capital Management LLC now owns 658,603 shares of the company’s stock worth $4,697,000 after purchasing an additional 68,764 shares in the last quarter. Marshall Wace LLP raised its holdings in 908 Devices by 359.4% in the 2nd quarter. Marshall Wace LLP now owns 648,796 shares of the company’s stock worth $4,626,000 after purchasing an additional 507,562 shares in the last quarter. First Eagle Investment Management LLC raised its holdings in 908 Devices by 3.3% in the 4th quarter. First Eagle Investment Management LLC now owns 623,883 shares of the company’s stock worth $3,275,000 after purchasing an additional 19,921 shares in the last quarter. Finally, Essex Investment Management Co. LLC lifted its stake in shares of 908 Devices by 3.5% in the 3rd quarter. Essex Investment Management Co. LLC now owns 493,949 shares of the company’s stock valued at $4,327,000 after purchasing an additional 16,607 shares during the period. 88.06% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Weiss Ratings cut shares of 908 Devices from a “hold (c-)” rating to a “sell (d-)” rating in a report on Monday, May 11th. Wall Street Zen cut shares of 908 Devices from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, 908 Devices has a consensus rating of “Hold” and an average price target of $12.00.

Insiders Place Their Bets

In other 908 Devices news, SVP John Kenneweg sold 7,787 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $6.83, for a total value of $53,185.21. Following the completion of the sale, the senior vice president owned 76,039 shares in the company, valued at $519,346.37. This represents a 9.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Kevin J. Mccallion sold 5,420 shares of the company’s stock in a transaction dated Thursday, April 9th. The stock was sold at an average price of $7.03, for a total value of $38,102.60. Following the completion of the sale, the senior vice president owned 44,925 shares of the company’s stock, valued at approximately $315,822.75. The trade was a 10.77% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 94,480 shares of company stock worth $668,032 over the last quarter. 28.20% of the stock is currently owned by corporate insiders.

908 Devices Stock Performance

MASS opened at $7.12 on Friday. The stock has a market capitalization of $269.21 million, a P/E ratio of -7.12 and a beta of 0.57. The company’s 50-day simple moving average is $6.80 and its two-hundred day simple moving average is $6.42. 908 Devices Inc. has a 52-week low of $4.47 and a 52-week high of $9.34.

908 Devices (NASDAQ:MASS) last posted its earnings results on Tuesday, March 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.01. The business had revenue of $17.38 million for the quarter, compared to analysts’ expectations of $16.19 million. 908 Devices had a negative net margin of 62.40% and a negative return on equity of 14.03%. Research analysts forecast that 908 Devices Inc. will post -0.38 EPS for the current fiscal year.

908 Devices Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.